Keynote speaker

Eric J. Topol

Cardiologist; Geneticist.
Author, The Creative Destruction of Medicine

A distinguished scientist and physician on the forefront of the digital medical technology revolution.

A premier cardiologist, genetic researcher, and technologist, Eric Topol sees the future of health care, and he likes what he sees. As a leader in the movement to modernize medical treat¬ment through the latest technology, Dr. Topol is creating new, more effective ways to treat patients — ways that will dramatically bring down the costs of health care.

Dr. Topol's new book is titled The Creative Destruction of Medicine: How The Digital Revolution Will Create Better Health Care. It's about how social networking, smart-phones and connectivity will change the medical field. Now with powerful new tools to sequence each individual's whole genome, and the unparalleled convergence of technology, we have a new window into what makes us tick, what makes us an individual. Consumers have the unprecedented capacity to take control of their own individual information and revolutionize medicine.

Dr. Topol is a leading medical researcher in the area of genomics, where his work has led to the discovery of the genes that increase a person's risk of heart attack. He has pioneered new drugs and new advances in the treatment of heart disease. He is working to bring a new kind of medicine into widespread practice: specifically-designed treatments based on the individual's unique genetic structure. This innovative approach...

Joseph F. Petrosino

Director, Alkek Center for Metagenomics and Microbiome Research
Baylor College of Medicine

Joseph F. Petrosino, Ph.D., is an Assistant Professor of Molecular Virology and Microbiology at Baylor College of Medicine where he is also the director of the Alkek Center for Metagenomics and Microbiome Research. He holds joint appointments in the Human Genome Sequencing Center, Department of Ophthalmology, and is a member of the Cell and Molecular Biology and Translational Biology and Molecular Medicine programs. He obtained his undergraduate degree in microbiology and immunology with a distinction...

Chris Corless

Medical Director of Knight Diagnostic Laboratories
Director of Molecular Pathology
Oregon Health & Science University

After undergraduate studies at the Univ. of California, Berkeley, Professor Corless received his MD and PhD degrees from Washington University, St. Louis. He did his residency training in Anatomic Pathology at the Brigham & Women's Hospital, Boston, where he also completed fellowship training in GI Pathology and GU Pathology. In 1994, he joined the faculty of Oregon Health & Science University as an Assistant Professor. He has served as the residency program director in Pathology and medical director of surgical pathology for OHSU...

Milan Radovich

Assistant Professor
Indiana University School of Medicine

Dr. Milan Radovich is an assistant professor at the Indiana University School of Medicine whose research focuses on the use of next-generation sequencing in translational oncology. In particular, his laboratory focuses on the use of sequencing for drug development, pharmacogenomics, and understanding mutational causation. In addition, a major focus of his work is integration of next-generation sequencing into cancer clinical trials with a special focus on using genomics for precision medicine...

Jun Wang

Executive Director
BGI (previously known as the Beijing Genomics Institute)

Jun Wang is the Executive Director of the BGI (previously known as the Beijing Genomics Institute). He was instrumental in the 1999 founding and the growth of the BGI Bioinformatics Department, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. Dr. Wang also holds a position as an Ole Rømer professor at the University of Copenhagen. He has authored 200+ peer-reviewed original papers – of which 80 are published in Cell, Nature...

William M. Strauss

Director, Molecular Biology
Cynvenio Biosystems Inc

Dr. Strauss is a molecular biologist with over 20 years of experience in eukaryotic and prokaryotic systems. Trained in chemistry at Columbia, and in genetics and immunology at Harvard, Bill received his post-doctoral training at MIT in the Whitehead Institute. His independent research has focused on the interface between stem/iPS cell biology and molecular biology. In Boston, Colorado, and San Diego he has employed advanced genomic technologies, including deep sequencing, to determine the properties of different human and mouse....

Dagan Wells

Nuffield Department of Obstetrics and Gynecology
University of Oxford

Dagan Wells has been involved in the genetic analysis of single cells for over two decades, focusing on the diagnosis of inherited conditions in human embryos produced using in vitro fertilization (preimplantation genetic diagnosis – PGD). He spent several years developing novel PGD tests at University College London, accomplishing the first comprehensive chromosome analysis of individual cells from human embryos in 1998, using a combination of whole genome amplification and comparative genomic...

Sandra Pinto Cardoso

Research Scientist
Research Center for Infectious Diseases, Mexico City

Dr. Sandra Pinto Cardoso is a research scientist at the Research Center for Infectious Diseases, Mexico City, leading a project looking at the role of the gut microbiota dysbiosis in HIV disease progression. In particular, she is interested in characterizing and comparing the gut microbiota of HIV-infected individuals at different stages of infection and with or without antiretroviral therapy by using the Ion Torrent PGM platform and 16S rRNA gene. She obtained her undergraduate degree in Molecular and Cell Biology, specializing in Immunology in 1998 from the University of Aix-Marseille II...

Steve Glavas

Head of NGS Platform
Swedish Institute for Communicable Disease Control

Steve Glavas is currently the Head of Next Generation Sequencing and Laboratory Automation at the Swedish Institute for Communicable Disease Control. He has an extensive background in liquid handling optimization, validation, and automation applied in many molecular methods ranging from oligo synthesis on a global level, classical PCR and sanger, as well as NGS. Currently he is moving high volume amplicon sequencing from sanger based methods to NGS for simplified analysis and sample handling...

Jeremy Stuart

Co-founder & Vice President
Selah Genomics Inc

Dr. Stuart currently serves as the VP of Clinical Services at Selah Genomics. After receiving his doctorate from Harvard University in Genetics & Complex Diseases, he became one of the founding R&D members of the SOLiD NGS platform, gaining extensive experience with NGS technologies and applications while co-authoring two patents in this space. He has collaborated closely with sites such as the Broad Institute and Memorial Sloan Kettering to integrate NGS methodologies into their research. Dr. Stuart currently oversees the clinical and analytical validation of the PGM-related assays as LDTs under CLIA standards and also directs the...

Marcel Nelen

Clinical Laboratory Geneticist
Radboud University Nijmegen, Medical Centre


Dr. Nelen is a clinical molecular geneticist heading the Core Genome Analysis Laboratory of the Human Genetics Department at the Radboud University Nijmegen Medical Centre (RUNMC) , The Netherlands. In close collaboration with the Genomic Disorders group headed by Dr. Veltman his laboratory was among the first to perform exome sequencing in a diagnostic setting. Dr. Nelen got his training as a laboratory specialist clinical genetics at the Department of Medical Genetics, UMC Utrecht, the Netherland where he was responsible...

Kuo Bianchini Tong

President and Founder
Quorum Consulting

Mr. Tong works with his clients to understand how economic, financial, and reimbursement forces can be managed and how to influence product acceptance and utilization. His consulting engagements focus on strategic planning and implementation in early phases of product development, during clinical evaluation, and following regulatory approval. Mr. Tong has worked across a number of different clinical specialties and therapeutic categories including: hematology and oncology; solid organ and bone marrow transplantation ; infectious diseases like HIV/AIDS and hepatitis; cardiovascular diagnostics...

Christian Thiede

Professor for Molecular Hematology
TU Dresden

Christian Thiede is a scientist with 20 years of experience in the field of molecular diagnostics, especially in the field of hematological malignancies. After finishing his medical education at the FU Berlin, he had three years of Post-Doctoral training in the Department for Hematology and Oncology at Humboldt University/Charité, Berlin. He then went to Dresden to build up a diagnostic laboratory at the newly established MedicalFaculty at the University of Technics in Dresden. His major focus is the understanding of the molecular mechanisms involved in leukemogenis, alterations involved in treatment resistance, as well as the use of this information...

Richard Allcock

LotteryWest State Biomedical Facility – Genomics (LSBFG), Royal Perth Hospital


Richard Allcock is a DNA sequencing-tragic who is the Scientist-in-Charge of the LotteryWest State Biomedical Facility – Genomics (LSBFG) based at Royal Perth Hospital in Western Australia. He is also a member of the School of Pathology and Laboratory Medicine at the University of Western Australia and a Founding Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia. is present focus is the application of genomics and next-generation sequencing techniques to ...

Peter N. Ray

Professor, Department of Molecular and Medical Genetics
University of Toronto


Dr. Peter N. Ray is a Professor in the Department of Molecular and Medical Genetics at the University of Toronto and Head of Molecular Genetics at the Hospital for Sick Children. Dr. Ray received his PhD from the Department of Medical Biophysics, University of Toronto for his work on the regulation of gene expression in the bacteriophage lambda. He then completed two years of post-doctoral training at the Stanford University School of Medicine in California studying the role of neural cell adhesion factors in the development of the embryonic eye...


Tom Reynolds

Executive VP and Co-Founder


Scientist, Entrepreneur and Executive with 25 years experience in the Life Sciences. Since Co-Founding AIBioTech (formerly Commonwealth Biotehnologies), in 1992, Reynolds has served as Vice President, Senior Vice President and Executive Vice President as well as Director of the Company. His current responsibilities include oversight of all DNA Services, Molecular Biology, Microbiology and BSL-3 labs and Clinical Molecular Diagnostics, Clinical Genetics and Personal Medicine related technologies and services including management oversight of the Fairfax Identity Laboratory division. Reynolds...

Jamie Platt

Scientific Director, Advanced Sequencing
Quest Diagnostics


Dr. Platt received her Ph.D. in Molecular & Cellular Biology from Oregon State University and completed postdoctoral training in population genetics at the University of California, Berkeley. She has extensive expertise in sequencing and molecular systematics, including population genetics. During her 11 years at Quest Diagnostics, Dr. Platt has developed and validated numerous high complexity sequencing assays in the clinical areas of Infectious Diseases, Oncology and Molecular Genetics and has...

Patrice Milos

Chief Executive Officer
Claritas Genomics

Dr. Milos recently joined Claritas Genomics, a newly formed company focused on pediatric molecular diagnostics emerging from Boston Children’s Hospital in partnership with Life Technologies. Claritas Genomics combines the power of next-generation DNA sequencing technology with the clinical expertise of the world’s best pediatric specialists to inform and improve patient care. Patrice most recently served as the Boston Site Head for Pfizer’s Centers of Therapeutic Innovation and Precision Medicine Lead. The CTI model represented a new and exciting approach to...

Our distinguished speakers will present results showing how they are using Ion PGM™ and Ion Proton™ Systems in these applications and research areas: gene panel sequencing for basic research, clinical research, inherited disease research, and cancer research.

  • Gene panel sequencing for basic and clinical inherited disease and cancer research
  • Aneuploidy assessment in reproductive genetics research
  • Microbial and infectious disease research
  • Exome sequencing to transform research into genetic disorders
  • Routine transcriptome sequencing for research
  • Next-generation sequencing applications for cancer research


*The content provided herein may relate to products that have not been officially released and is subject to change without notice.
For Research Use Only.  Not for use in diagnostic procedures.